相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prognostic role of neutrophil- to- lymphocyte ratio in colorectal cancer: A systematic review and meta- analysis
Mu-Xing Li et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Cancer-related inflammation and treatment effectiveness
Connie I. Diakos et al.
LANCET ONCOLOGY (2014)
An Inflammation Based Score Can Optimize the Selection of Patients with Advanced Cancer Considered for Early Phase Clinical Trials
David J. Pinato et al.
PLOS ONE (2014)
A systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumours
Ashvin Paramanathan et al.
SURGICAL ONCOLOGY-OXFORD (2014)
Preoperative Plasma Hyperfibrinogenemia is Predictive of Poor Prognosis in Patients with Nonmetastatic Colon Cancer
Hae-Jung Son et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes
George Pentheroudakis et al.
BMC CANCER (2013)
Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy
J. M. Juergensmeier et al.
BRITISH JOURNAL OF CANCER (2013)
Circulating IL-6 concentrations link tumour necrosis and systemic and local inflammatory responses in patients undergoing resection for colorectal cancer
G. J. K. Guthrie et al.
BRITISH JOURNAL OF CANCER (2013)
Optimization of the systemic inflammation-based Glasgow Prognostic Score
Michael J. Proctor et al.
CANCER (2013)
Prognostic and Predictive Blood-Based Biomarkers in Patients with Advanced Pancreatic Cancer: Results from CALGB80303 (Alliance)
Andrew B. Nixon et al.
CLINICAL CANCER RESEARCH (2013)
The systemic inflammation-based neutrophil-lymphocyte ratio: Experience in patients with cancer
Graeme J. K. Guthrie et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
A novel predictive strategy by immunohistochemical analysis of four EGFR ligands in metastatic colorectal cancer treated with anti-EGFR antibodies
Michihiro Yoshida et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment
Takashi Motomura et al.
JOURNAL OF HEPATOLOGY (2013)
Cytokine patterns in patients with cancer: a systematic review
Bodo E. Lippitz
LANCET ONCOLOGY (2013)
Prognostic Significance of a Systemic Inflammatory Response in Patients Undergoing Multimodality Therapy for Advanced Colorectal Cancer
Yasuhiro Inoue et al.
ONCOLOGY (2013)
In Patients with Colorectal Cancer, Preoperative Serum Interleukin-6 Level and Granulocyte/Lymphocyte Ratio Are Clinically Relevant Biomarkers of Long-Term Cancer Progression
Jiro Shimazaki et al.
ONCOLOGY (2013)
Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
Lisa M. Coussens et al.
SCIENCE (2013)
Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer
Atil Bisgin et al.
BMC CANCER (2012)
Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma
T. Kantola et al.
BRITISH JOURNAL OF CANCER (2012)
A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer
M. J. Proctor et al.
BRITISH JOURNAL OF CANCER (2012)
Down-regulation of CXCL1 inhibits tumor growth in colorectal liver metastasis
Obul R. Bandapalli et al.
CYTOKINE (2012)
Molecular Targets of TRAIL-Sensitizing Agents in Colorectal Cancer
Carmine Stolfi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
Dysplasia-Carcinoma Transition Specific Transcripts in Colonic Biopsy Samples
Orsolya Galamb et al.
PLOS ONE (2012)
Histopathologic-Based Prognostic Factors of Colorectal Cancers Are Associated With the State of the Local Immune Reaction
Bernhard Mlecnik et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer
Marco Erreni et al.
CANCER MICROENVIRONMENT (2011)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Serum interleukin-6 levels in colorectal cancer patients-a summary of published results
Heike Knuepfer et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2010)
Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
Scott Kopetz et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
Peter M. Rothwell et al.
LANCET (2010)
Blood Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients with Colorectal Liver Metastases Treated with Systemic Chemotherapy
Yoji Kishi et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Francesco Colotta et al.
CARCINOGENESIS (2009)
Tumor immunotherapy in melanoma - Strategies for overcoming mechanisms of resistance and escape
Maya Zigler et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2008)
Preoperative C-Reactive Protein as a Prognostic and Therapeutic Marker for Colorectal Cancer
Yuhki Koike et al.
JOURNAL OF SURGICAL ONCOLOGY (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Correlation of IL-8 with induction, progression and metastatic potential of colorectal cancer
Claudia Rubie et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis
Barbara Mroczko et al.
CLINICA CHIMICA ACTA (2007)
GROα is highly expressed in adenocarcinoma of the colon and down-regulates fibulin-1
Yu Wen et al.
CLINICAL CANCER RESEARCH (2006)
CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer
DZ Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Lessons from TRAIL-resistance mechanisms in colorectal cancer cells: paving the road to patient-tailored therapy
CMM Van Geelen et al.
DRUG RESISTANCE UPDATES (2004)
分享论文
